Cover Image

DIFFERENCES IN LIPOPROTEIN(A) BY RACE, ETHNICITY, AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK

Therapeutic Area: ASCVD/CVD Risk Factors Background: Lipoprotein(a) [Lp(a)] is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD). Despite practice guidelines recommending routine Lp(a) testing, uptake of screening has been low and variable. We sought to understand differences i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ramzi Dudum, MD MPH (Author), Qiwen Huang, MS (Author), Xiaowei (Sherry) (Author), Powell Jose, MD (Author), Sumeet Singh Brar, MD (Author), Ashish Sarraju, MD (Author), Fatima Rodriguez, MD MPH (Author)
Format:	Book
Published:	Elsevier, 2023-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024)

Impact of Race on Classification of Atherosclerotic Risk Using a National Cardiovascular Risk Prediction Tool
by: Jarett R. Beaudoin, MD, MPH, et al.
Published: (2024)

Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol
by: Yonghong Luo MD, et al.
Published: (2023)

RELATIONSHIP BETWEEN SOCIOECONOMIC STATUS, CORONARY ARTERY CALCIUM AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A MULTI-COHORT STUDY
by: Taylor Triana, MD, MBA, et al.
Published: (2023)

SEX DIFFERENCES IN THE ASSOCIATION BETWEEN LIPOPROTEIN (A) AND MYOCARDIAL INFARCTION IN PATIENTS WITH NO ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: THE MASS GENERAL BRIGHAM LP(A) REGISTRY
by: Gurleen Kaur, MD, et al.
Published: (2023)

114 - PREVALENCE OF SOCIAL DETERMINANTS AMONG US RESIDENTS WITH HEART FAILURE BY RACE/ETHNICITY AND HOUSEHOLD INCOME
by: Lajjaben Patel, MBBS, et al.
Published: (2023)

LIPOPROTEIN(A) ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE DEVELOPMENT AND PREDICTION IN PRIMARY PREVENTION FROM REAL-WORLD DATA
by: Wenjun Fan, MD, PhD
Published: (2024)

EVALUATING MISINFORMATION REGARDING CARDIOVASCULAR DISEASE PREVENTION OBTAINED ON A POPULAR, PUBLICLY ACCESSIBLE ARTIFICIAL INTELLIGENCE MODEL (GPT-4)
by: Ashish Sarraju, MD
Published: (2024)

BODY WEIGHT, LIPOPROTEIN (A), AND INCIDENT CARDIOVASCULAR DISEASE IN THE UK BIOBANK
by: Richard Kazibwe, MD, MS
Published: (2024)

UTILIZATION OF OPTIMAL MEDICAL PHARMACOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM AN INTEGRATED HEALTHCARE SYSTEM
by: Izza Shahid, MBBS, et al.
Published: (2023)

PROGNOSTIC VALUE OF LIPOPROTEIN(A) FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RELATION TO C-REACTIVE PROTEIN - A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Pamela L. Alebna, MD, MPH
Published: (2024)

Lung Cancer Screening Among U.S. Military Veterans by Health Status and Race and Ethnicity, 2017-2020: A Cross-Sectional Population-Based Study
by: Alison S. Rustagi, MD, PhD, et al.
Published: (2023)

Cohort Study of Downgraded Misdemeanor Convictions and Subsequent Violent Crime: Differences by Defendant Race and Ethnicity
by: Julia P. Schleimer, MPH, et al.
Published: (2024)

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease
by: Constantine E Kosmas, et al.
Published: (2018)

INTERSECTION OF RACE, INCOME AND CARDIOVASCULAR DISEASES IN THE UNITED STATES
by: Abdul Mannan Khan Minhas, MD, et al.
Published: (2023)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
by: Fumiaki Ito, et al.
Published: (2020)

Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
by: Emily Keyes, BA, et al.
Published: (2021)

Vaccination during pregnancy by race/ethnicity: a focus on American Indians/Alaska NativesAJOG Global Reports at a Glance
by: Christen L. Jarshaw, MD, et al.
Published: (2024)

Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
by: Zulqarnain Javed, et al.
Published: (2021)

Fatherhood and Cardiovascular Health, Disease, and Mortality: Associations From the Multi-Ethnic Study of Atherosclerosis
by: John James F. Parker, MD, MS, et al.
Published: (2024)

Representation of sex, race, and ethnicity in pivotal clinical trials for dermatological drugs
by: Jeffrey Ding, et al.
Published: (2021)

Reported Sports Participation, Race, Sex, Ethnicity, and Obesity in US Adolescents From NHANES Physical Activity (PAQ_D)
by: Robert W. Turner PhD, et al.
Published: (2015)

Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
by: Federica Galimberti, et al.
Published: (2023)

The role of gender, race, and ethnicity in psoriasis patients with COVID-19 infection: A cross-sectional study
by: Cristina Nguyen, MD, MSBS, MHA, et al.
Published: (2022)

Postpartum readmission in Maryland by race and ethnicity, 2016-2019AJOG Global Reports at a Glance
by: Sonia Hamilton, BS, et al.
Published: (2023)

Differences in Report of Post-COVID Conditions Among Adults Tested for SARS-CoV-2 by Race and Ethnicity: 2022 Porter Novelli SummerStyles Survey, U.S.
by: Leora R. Feldstein, PhD, MSc, et al.
Published: (2024)

Diffuse xanthomas in a patient with primary biliary cholangitis and lipoprotein X
by: Jasmine Harris, MS, et al.
Published: (2021)

Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement
by: Danielle Belardo, MD, et al.
Published: (2022)

Impact of Race/Ethnicity and Socioeconomic Status on Risk-Adjusted Readmission Rates
by: Grant R. Martsolf PhD, et al.
Published: (2016)

Impact of race versus ethnicity on infertility diagnosis between Black American, Haitian, African, and White American women seeking infertility care: a retrospective review
by: Roxane C. Handal-Orefice, M.D, et al.
Published: (2022)

Race and Ethnicity in Real-World Data Sources: Considerations for Medical Device Regulatory Efforts
by: Michelle E. Tarver MD, PhD
Published: (2021)

CHARACTERISTICS AND RISK FACTORS OF YOUNG ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN AN UNDERREPRESENTED COHORT: INSIGHTS FROM THE ALL OF US RESEARCH PROGRAM
by: Sara J. King, MD
Published: (2024)

Online Patient Education Materials Related to Lipoprotein(a): Readability Assessment
by: Keon Pearson, et al.
Published: (2022)

Estimated Aggregate Treatment Benefit With Addition of Multiple Novel Medications for Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Robert W. Ariss BS, et al.
Published: (2022)

LIPOPROTEIN(A) AND CARDIOVASCULAR RISK. A RETROSPECTIVE COHORT STUDY FROM NYC/HHC+ PUBLIC HOSPITAL IN NEW YORK CITY
by: Natalia Nazarenko, MD
Published: (2024)

Diffuse xanthomas in a patient with lipoprotein X hyperlipidemia
by: Katherine Grace Byrnes, BS, et al.
Published: (2023)

Gastric Xanthomatosis Secondary to Lipoprotein X in Primary Biliary Cholangitis
by: Erin Petrie MD, et al.
Published: (2022)

CAC-BASED CARDIOVASCULAR RISK STRATIFICATION AMONG INDIVIDUALS WITH OBESITY BUT WITHOUT DIABETES
by: Erfan Tasdighi, MD, et al.
Published: (2023)

Race and ethnicity expression in reproductive endocrinology and infertility research studies compared with other obstetrics and gynecology subspecialty studies
by: Anne Roshong, M.D, et al.
Published: (2024)

Race, Income, and Insurance Status Are Associated with Increased Time to Initial Outpatient Evaluation of Fracture Patients
by: Sumit K. Gupta, MD, MPH, et al.
Published: (2024)